Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 162

1.

Urinary C‑X‑C motif chemokine 13 is a noninvasive biomarker of antibody‑mediated renal allograft rejection.

Chen D, Zhang J, Peng W, Weng C, Chen J.

Mol Med Rep. 2018 Aug;18(2):2399-2406. doi: 10.3892/mmr.2018.9211. Epub 2018 Jun 22.

PMID:
29956754
2.

CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.

Niederkorn A, Frühauf J, Schwantzer G, Wutte N, Painsi C, Werner S, Stradner M, Berghold A, Hermann J, Aberer E.

Arch Dermatol Res. 2018 Aug;310(6):485-493. doi: 10.1007/s00403-018-1836-6. Epub 2018 May 4.

PMID:
29728857
3.

CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.

Mandal SK, Sandhya P, Kabeerdoss J, Ramya J, Mahasampath G, Danda D.

Rheumatol Int. 2018 May;38(5):831-836. doi: 10.1007/s00296-018-4006-4. Epub 2018 Mar 14.

PMID:
29541901
4.

Association of CXCL13 serum level and ultrasonographic findings of joints in patients with systemic lupus erythematosus and Jaccoud's arthropathy.

Ribeiro DS, Lins CF, Galvão V, Santos WGD, Rosa G, Machicado V, Pedreira AL, da Fonseca EP, Souza APMD, Baleeiro C, Ferreira LG, Oliveira IS, Gama da Silva JPC, Atta AM, Santiago MB.

Lupus. 2018 May;27(6):939-946. doi: 10.1177/0961203317753557. Epub 2018 Jan 16.

PMID:
29338586
5.

Chemokine CXC Ligand 13 in Cerebrospinal Fluid Can Be Used as an Early Diagnostic Biomarker for Lyme Neuroborreliosis: A Meta-Analysis.

Yang J, Han X, Liu A, Bao F, Peng Y, Tao L, Ma M, Bai R, Dai X.

J Interferon Cytokine Res. 2017 Oct;37(10):433-439. doi: 10.1089/jir.2016.0101. Epub 2017 Oct 3.

PMID:
28972436
6.

Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.

Remy MM, Schöbi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F.

J Neuroinflammation. 2017 Aug 31;14(1):173. doi: 10.1186/s12974-017-0948-9.

7.

Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.

Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Øymar K.

Pediatr Infect Dis J. 2017 Dec;36(12):e286-e292. doi: 10.1097/INF.0000000000001669.

PMID:
28661964
8.

Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis.

He N, Chen WL, Long KX, Zhang X, Dong GF.

J Immunol Res. 2016;2016:4832543. Epub 2016 Nov 20.

9.

Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus.

Wan Z, Lin X, Li T, Zhou A, Yang M, Hu D, Feng L, Peng S, Fan L, Tu S, Bin Zhang, Du Y.

Sci Rep. 2016 May 23;6:26465. doi: 10.1038/srep26465.

10.

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Olsson KM, Olle S, Fuge J, Welte T, Hoeper MM, Lerch C, Maegel L, Haller H, Jonigk D, Schiffer L.

Respir Res. 2016 Feb 29;17:21. doi: 10.1186/s12931-016-0336-5.

11.

CXCL13 is a plasma biomarker of germinal center activity.

Havenar-Daughton C, Lindqvist M, Heit A, Wu JE, Reiss SM, Kendric K, Bélanger S, Kasturi SP, Landais E, Akondy RS, McGuire HM, Bothwell M, Vagefi PA, Scully E; IAVI Protocol C Principal Investigators, Tomaras GD, Davis MM, Poignard P, Ahmed R, Walker BD, Pulendran B, McElrath MJ, Kaufmann DE, Crotty S.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2702-7. doi: 10.1073/pnas.1520112113. Epub 2016 Feb 23.

12.

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling.

Li C, Kang D, Sun X, Liu Y, Wang J, Gao P.

Biomed Res Int. 2015;2015:345413. doi: 10.1155/2015/345413. Epub 2015 Jun 16.

13.

ASSOCIATION BETWEEN AQUEOUS HUMOR CXC MOTIF CHEMOKINE LIGAND 13 LEVELS AND SUBFOVEAL CHOROIDAL THICKNESS IN NORMAL OLDER SUBJECTS.

Nomura Y, Takahashi H, Fujino Y, Kawashima H, Yanagi Y.

Retina. 2016 Jan;36(1):192-8. doi: 10.1097/IAE.0000000000000668.

PMID:
26121407
14.

Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.

Ferraro D, Galli V, Vitetta F, Simone AM, Bedin R, Del Giovane C, Morselli F, Filippini MM, Nichelli PF, Sola P.

J Neuroimmunol. 2015 Jun 15;283:64-9. doi: 10.1016/j.jneuroim.2015.04.011. Epub 2015 Apr 25.

PMID:
26004159
15.

The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.

Chen L, Huang Z, Yao G, Lyu X, Li J, Hu X, Cai Y, Li W, Li X, Ye C.

J Transl Med. 2015 May 20;13:168. doi: 10.1186/s12967-015-0521-1. Erratum in: J Transl Med. 2016 Nov 15;14 (1):318.

16.

The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.

Kim SJ, Ryu KJ, Hong M, Ko YH, Kim WS.

J Hematol Oncol. 2015 May 14;8:49. doi: 10.1186/s13045-015-0142-4. Erratum in: J Hematol Oncol. 2015;8(1):112.

17.
18.

Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.

Hu R, Lu C, Lu S, Hu Y, Ma H, Lai W, Zhu G, Feng P, Lu R, Li Y.

Int J STD AIDS. 2016 Feb;27(2):141-6. doi: 10.1177/0956462415577229. Epub 2015 Mar 12.

PMID:
25769888
19.

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Li Y, Wang W, Tang L, He X, Yan X, Zhang X, Zhu Y, Sun J, Shi Y, Ma X, Mackay IR, Gershwin ME, Han Y, Hou J.

Hepatology. 2015 Jun;61(6):1998-2007. doi: 10.1002/hep.27725. Epub 2015 Mar 18.

20.

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'.

Greisen SR, Schelde KK, Rasmussen TK, Kragstrup TW, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Deleuran B, Hvid M.

Arthritis Res Ther. 2014 Sep 24;16(5):434. doi: 10.1186/s13075-014-0434-z.

Supplemental Content

Support Center